In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
201 News Items found
MSK scientists Andrew Kung and Elli Papaemmanuil
New Type of Genetic Testing Aims To Benefit Children and Young Adults With Cancer

By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.
(Left to right) Medical oncologist Mark Robson, gynecologist Noah Kauff, medical oncologist Zsofia Stadler, and Clinical Genetics Service Chief Kenneth Offit are applying genetic insights to improve the care of cancer patients.
Genetic Information Becomes a Vital Part of Clinical Practice

At Memorial Sloan Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients.
Michael Postow, Nitya Raj and Triparna Sen
MSK Leaders Recognized in the 40 Under 40 in Cancer Class of 2020

Chief of the Melanoma Service Michael Postow, MD, Medical Oncologist Nitya Raj, MD, and Assistant Attending Triparna Sen, PhD were included on this year’s list.
Joan Massagué leads Memorial Sloan Kettering's Metastasis Research Center
Opening Cancer's Black Box

The Metastasis Research Center has brought together 27 Memorial Sloan Kettering laboratories to facilitate research on metastasis and its treatment.
Bridget Anderson
Fecal Transplants Boost Helpful Microbiota for Stem Cell Transplant Patients

To help some patients to overcome leukemia, MSK doctors are calling upon patients’ microbiomes — the vast ecosystems of microorganisms that live within us, especially the gut. These microbes appear to help some patients recover from bone marrow and stem cell transplants.
Three syringes stuck into an orange and white bull’s-eye
In the Clinic
Drug Targeting Genetic Mutation Works across All Tumor Types

A drug effective in all cancer types with a mutation called a TRK fusion could be the first ever developed simultaneously in adults and children.
Piro Lito, Bob Li, and Neal Rosen in the lab
In the Clinic
Promising Results from the First-Ever Trial of a Drug that Blocks Cancer Gene KRAS

The drug, sotorasib, is targeted against a cancer-causing protein that has long been considered an “undruggable” target.
Selwyn M. Vickers, MD, FACS
A Message From MSK’s President and CEO, Dr. Selwyn Vickers

In cancer care, firsts make a difference. At MSK, we are constantly improving how we help people with those important firsts. Dr. Selwyn Vickers writes about the latest developments at MSK and the encouraging evidence that we are making progress in our mission of ending cancer for life.
Illustration of human neck and head with thyroid gland highlighted and tumor growing on gland.
Science Byte
Breaking Bad: Researchers Find Mutations that Turn Thyroid Cancers Deadly

MSK researchers identify mutations that convert nonthreatening thyroid tumors into aggressive cancers.
Detail shot of a nurse holding hands with a patient
MSK Research Highlights, May 10, 2024

New MSK research measures unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies; investigates oral bacteria’s link to gut microbiota depletion with implications for cancer patients; and shows how a universal opt-out approach could help more cancer patients quit smoking.